ARC
SGYP

Absolute Return Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Absolute Return Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-77,675
Closed -$412K – 1461
2014
Q1 		$412K Buy
+77,675
New +$435K 0.01% 890

Other funds holding SGYP

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Absolute Return Capital's SGYP Position: Q2 2014 in Review

Absolute Return Capital sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2014, closing a stake of 77,675 shares — an estimated $412K sold.

Absolute Return Capital first reported a position in SGYP in Q1 2014 and held it in 1 quarter. The position peaked at $412K in Q1 2014. 86 funds tracked by Wall St. Rank hold SGYP as of Q2 2014.

  • Absolute Return Capital reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2014 after selling out during the quarter.
  • Absolute Return Capital sold 77,675 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2014, an estimated $412K.
  • Absolute Return Capital first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2014 and held it in 1 quarter.
  • Absolute Return Capital's Synergy Pharmaceuticals, Inc Common Stock position peaked at $412K in Q1 2014.
  • 86 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2014.

Based on Absolute Return Capital's 13F filing for Q2 2014, filed 14 Aug 2014.